Latest stories on SPRO
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics files $300M mixed securities shelf
The Fly28 · bearishgeneral
Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Spero Therapeutics (SPRO) Q2 2026 Earnings Call Transcript
The Motley Fool55 · neutralearnings
Spero outlines cash runway into the second half of 2029 following $105M royalty financing
Seeking Alpha56 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Spero Therapeutics Q2 Earnings Call Highlights
Yahoo Finance67 · bullishearnings
Spero Therapeutics GAAP EPS of -$0.16
Seeking Alpha34 · bearishearnings
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
StockTitan42 · neutralearnings
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
GlobeNewswire48 · neutralearnings
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
StockTitan50 · neutralgeneral
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
StockTitan56 · neutralgeneral
Spero Therapeutics: 'Buy' On Utebzi Royalty Deal For Funding And SP001 In-Licensing
Seeking Alpha63 · neutralanalyst
Spero gets ex-China rights to Innovent’s antibody therapy for up to $1.1B
Seeking Alpha67 · bullishm&a
At a glance: stocks gapping down premarket
Seeking Alpha32 · bearishgeneral
Spero Therapeutics Lands $105 Million Royalty Financing to Advance SP001 Development (SPRO)
InvestorsHub58 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics Expands Stock Incentive Plan and Authorization
TipRanks50 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral